NYSE · Health Care · Diagnostics & Research
DHR
Danaher Corporation
Roll-up of bioprocessing and diagnostics businesses selling consumables and test kits to biotech manufacturers and hospital labs.
$202.45-0.71%
Close · 2026-08-14$160$180$200$220$240
NovFebMayAug
$160.60
$241.7852-week range, last close at 52% of the range
- 1W
- -1.13%
- 1M
- +0.83%
- 3M
- +25.30%
- 6M
- -4.36%
- YTD
- -11.19%
- 1Y
- -2.99%
- Avg vol 20d
- 6.4M
- RVOL
- 0.35
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $142.32B
- P/E
- 36.1
- Fwd P/E
- 21.8
- EPS
- $5.61
- Div yield
- 0.79%
- Beta
- 0.80
- Employees
- 58K
- Next earnings
- 2026-10-20
Rating & verdict historyoldest → newest
0.0% correct+2.25% avg moveBUY 0/0 · HOLD 0/0 · SELL 0/1
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |